⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TPST News
Tempest Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
TPST
Form 8-K
sec.gov
TPST
Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
globenewswire.com
TPST
Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
globenewswire.com
TPST
Form 8-K
sec.gov
TPST
Interim Management Statement H1 2026
globenewswire.com
PFG
ITIC
CTRN
TPST
NG
Form 8-K
sec.gov
TPST
VRTX
AMGN
AZN
BMY
FLEX
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
globenewswire.com
TPST
Form 8-K
sec.gov
TPST
Form 8-K
sec.gov
TPST